Tumor metastasis co-opts liver hematopoiesis to promote immunosuppression

Cancer-associated hematopoietic abnormalities contribute to systemic immunosuppression. However, whether tumors can initiate localized extramedullary hematopoiesis to suppress antitumor immunity remains unclear. In this study, we identify a distinct form of hepatic hematopoiesis driven by liver metastasis–associated hematopoietic stem cells (LM-HSCs). Liver metastases establish ectopic periportal hematopoietic niches that recruit bone marrow HSCs through Kupffer cell–dependent C-C motif chemokine receptor 1 (CCR1) signaling. Although LM-HSCs retain self-renewal and multipotency, cAMP response element–binding protein (CREB) activation skews their differentiation toward the myeloid lineage, particularly annexin A1–positive (ANXA1 + ) immature neutrophils. These neutrophils produce glucocorticoids, which activate glucocorticoid receptor signaling in a paracrine manner and induce immune checkpoint receptor expression and functional anergy in CD8 + T and natural killer cells. Collectively, these findings suggest that liver metastases reprograms hepatic hematopoiesis to promote immunosuppression.

Authors

Institutions

Publication Details

Journal
Science
Published
2026-11-05
DOI
https://doi.org/10.1126/science.aea3046
Primary Topic
Immune cells in cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Tumor metastasis co-opts liver hematopoiesis to promote immunosuppression

Naiheng Lin, Le Zhang, Ying Han, Aoyuan Cui et al.
Science
Immune cells in cancer
article

Tumor metastasis co-opts liver hematopoiesis to promote immunosuppression

Naiheng Lin, Le Zhang, Ying Han, Aoyuan Cui, Xuege Wang, Beitao Xu, Jun Qin, Wei Lü, Junjie Peng, Zhengquan Yu, Yannan Lian, Yu Li, Lan Wang, Xiaoming Wang, Guihua Wang, Yaqi Li, Xin Zeng, Zige Jin, Jiacheng Guo, Yongqiang Gu, Qiang Pan, Guoying Zhang, Ni Li, Wei Zhang
article en

Abstract

Cancer-associated hematopoietic abnormalities contribute to systemic immunosuppression. However, whether tumors can initiate localized extramedullary hematopoiesis to suppress antitumor immunity remains unclear. In this study, we identify a distinct form of hepatic hematopoiesis driven by liver metastasis–associated hematopoietic stem cells (LM-HSCs). Liver metastases establish ectopic periportal hematopoietic niches that recruit bone marrow HSCs through Kupffer cell–dependent C-C motif chemokine receptor 1 (CCR1) signaling. Although LM-HSCs retain self-renewal and multipotency, cAMP response element–binding protein (CREB) activation skews their differentiation toward the myeloid lineage, particularly annexin A1–positive (ANXA1 + ) immature neutrophils. These neutrophils produce glucocorticoids, which activate glucocorticoid receptor signaling in a paracrine manner and induce immune checkpoint receptor expression and functional anergy in CD8 + T and natural killer cells. Collectively, these findings suggest that liver metastases reprograms hepatic hematopoiesis to promote immunosuppression.

ScienceVol. 394(6824)
Shanghai Medical College of Fudan University (CN), Fudan University (CN), Zhengzhou University (CN), Fudan University Shanghai Cancer Center (CN), Shanghai Institute of Nutrition and Health (CN), Tongji Hospital (CN), University of Chinese Academy of Sciences (CN), Jinfeng Laboratory (CN), Huazhong University of Science and Technology (CN), China Agricultural University (CN), Nanjing Medical University (CN)
Openalex Percentile: Top 20%
Immune cells in cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon